July 30 − August 1, 2015Hilton Orlando Bonnet Creek

Orlando, FL

• Outstanding Presentations by Experts, Authors, and Leaders in Addiction Medicine• Strategic Curriculum Mapped to the ABAM Examination Blueprint• Exclusive Access to the 2015 Board Examination Study Tool – the BEST• New - Fast-paced Board Exam Practice Questions• Extensive Printed and Electronic Syllabus• Thursday Night Networking Reception with Colleagues and Experts • Two Timely and Valuable Pre-Course Offerings with additional CME

Bonus Features:

FOR OFFICE-BASED TREATMENT OF OPIOID USE DISORDERS

The Essential Primer for Physicians and Health Care Professionals in Addiction Medicine

Pre-courses - Wednesday, July 29, 2015

Approved for AMA PRA Category

1 Credits™

July 31 – August 1, 2015Hilton Orlando Bonnet Creek | Orlando, FL

OverviewThe ASAM Board Review Course in Addiction Medicine is widely recognized as the essential primer for physicians and other health care professionals who are preparing for a career in addiction medicine, as well as for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

The course offers three days of sessions which are mapped to the ABAM blueprint of topics for the exam and features an outstanding faculty. Over 800 professionals attended the 2014 ASAM Review Course in September 2014 in Orlando, Florida. ASAM’s Review Courses have had a major impact on advancing a common base of scientific knowledge among physicians and other health care professionals.

Note: ASAM and the California Society of Addiction Medicine (CSAM) will be alternating offering of the Review Course for the next two years. ASAM will offer the Review Course in 2015 and CSAM will offer the Review Course in 2016.

The American Board of Addiction MedicineThe American Board of Addiction Medicine (ABAM) is a separate entity from the American Society of Addiction Medicine (ASAM). ABAM certifies addiction medicine physician across a range of medical specialties. It is an independent specialty board established in 2007. The upcoming Board Examination for Addiction Medicine is October 17, 2015. Visit www.abam.net for more information.

Learning ObjectivesUpon completion, participants should be able to:

• Demonstrate practical knowledge the neurobiology of addiction and articulate its activity in terms useful in a clinical setting

• Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals

• Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders

• Explain the various pharmacologic and psychosocial treatments for addictive disorders, and describe the factors that should be considered in selecting a treatment modality to match a particular patient’s needs

• Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse.

Review Course Program Planning CommitteePetros Levounis, MD, MA, FASAM, Chair - Course DirectorRutgers New Jersey Medical School, New York, NY

Abigail Herron, DO, Vice-Chair - Course DirectorThe Institute for Family Health, New York, NY

Paul H. Earley, MD, FASAMEarly Consultancy, LLC, Atlanta, GA

David Galbis-Reig, MDWheaton Franciscan Healthcare, Kenosha, WI

Edwin A. Salsitz, MD, FASAMMount Sinai Beth Israel, New York, NY

Kenneth Thompson, MD, FASAMCaron Treatment Centers, Strasburg, PA

2

Faculty PresentersPetros Levounis, MD, MA, FASAMAbigail Herron, DOTimothy K. Brennan, MD, MPHPaul H. Earley, MD, FASAMMirela Feurdean, MDTimothy Fong, MDDavid Galbis-Reig, MD

Stuart Gitlow, MD, MPH, MBA, FAPAJames W. Finch, MD, FASAMDavid Mee-Lee, MDCara Poland, MD, MEdRicardo Restrepo, MD, MPHEdwin A. Salsitz, MD, FASAMKenneth Thompson, MD, FASAMTimothy Wiegand, MDErin Zerbo, MD

Excellent course! My patients will definitely benefit. - 2014 Course Attendee, WY

Wednesday, July 29, 2015

Pre-Courses11:00 am – 8:00 pmRegistration Open12:00 pm – 5:00 pmTabletop Exhibits/Set-up12:30 pm – 4:45 pmThe ASAM Buprenorphine Course 5:45 pm – 9:00 pmER/LA Opioid REMS Course

Thursday, July 30, 2015 Foundations of Addiction Medicine6:45 am – 7:45 amMutual Help7:00 am – 7:45 amContinental Breakfast

7:00 am – 6:30 pmRegistration Open7:00 am – 6:30 pmTabletop Exhibits Open

7:45 am – 8:00 amIntroduction and Opening RemarksPetros Levounis, MD, MA, FASAM; Abigail Herron, DO

8:00 am – 8:45 amSession 1: AlcoholRicardo Restrepo, MD, MPH

8:45 am – 9:30 amSession 2: SedativesRicardo Restrepo, MD, MPH

9:30 am – 10:15 amSession 3: OpioidsEdwin A. Salsitz, MD, FASAM

10:15 am – 10:45 amRefreshment Break10:45 am – 11:30 amSession 4: TobaccoTimothy K. Brennan, MD, MPH

11:30 am – 12:15 pmSession 5: CannabisPetros Levounis, MD, MA, FASAM

12:15 pm – 1:15 pmLunch (Grab-N-Go available for purchase)

1:15 pm – 1:30 pmBoard Exam Practice Questions with Audience Response System (ARS)Paul Earley, MD, FASAM

1:30 pm – 2:15 pmSession 6: StimulantsPetros Levounis, MD, MA, FASAM

2:15 pm – 2:30 pmSession 7: Other Classes of DrugsErin Zerbo, MD

3:00 pm – 3:30 pmRefreshment Break

3:30 pm – 4:15 pmSession 8: Behavioral AddictionsTimothy Fong, MD

4:15 pm – 4:30 pmBoard Exam Practice Questions with Audience Response System (ARS)Paul Earley, MD, FASAM

4:30 pm – 5:30 pmDay 1 – Expert Panel Discussion and Q&A5:30 pm – 6:30 pmNetworking Reception

Friday, July 31, 2015

Assessments and Treatments6:45 am – 7:45 amMutual Help7:00 am – 7:45 amContinental Breakfast

7:00 am – 5:00 pmRegistration Open7:00 am – 5:00 pmTabletop Exhibits Open

7:45 am – 8:00 amRemarks and Board Exam Practice Questions with Audience Response System (ARS)Petros Levounis, MD, MA, FASAM; Abigail Herron, DO; Paul Earley, MD, FASAM

8:00 am – 8:45 amSession 9: History of Addiction TreatmentStuart Gitlow, MD, MPH, MBA, FAPA

8:45 am – 9:30 amSession 10: The Neurobiology of AddictionPetros Levounis, MD, MA, FASAM

9:30 am – 10:15 amSession 11: EpidemiologyCara Poland, MD

10:15 am – 10:45 amRefreshment Break

10:45 am – 11:30 amSession 12: Definitions, the ASAM Criteria and the DSM-5David Mee-Lee, MD

11:30 am – 12:15 pmSession 13: Cognitive Behavior Therapy & Motivational InterviewingJames W. Finch, MD, FASAM

12:15 pm – 1:15 pmLunch (Grab-N-Go available for purchase)

1:15 pm – 1:30 pmBoard Exam Practice Questions with Audience Response System (ARS)Paul Earley, MD, FASAM

1:30 pm – 2:15 pmSession 14: 12-Step Facilitation and Other Psychosocial InterventionsJames W. Finch, MD, FASAM

2:15 pm – 3:00 pmSession 15: Psychiatric Co-MorbiditiesDavid Galbis-Reig, MD

3:00 pm – 3:30 pmRefreshment Break 3:30 pm – 4:15 pmSession 16: Medical Co-MorbiditiesCara Poland, MD, MEd

4:15 pm – 4:30 pmBoard Exam Practice Questions with Audience Response System (ARS)Paul Earley, MD, FASAM

4:30 pm – 5:30 pmDay 2 – Expert Panel Discussion and Q&A

Saturday, August 1, 2015

Special Populations and Topics6:30 am – 7:30 amMutual Help7:00 am – 7:30 amContinental Breakfast7:00 am – 10:30 amTabletop Exhibits Open 7:00 am – 1:00 pmRegistration Open7:30 am – 7:45 amRemarks and Board Exam Practice Questions with Audience Response System (ARS)Petros Levounis, MD, MA, FASAM; Abigail Herron, DO; Paul Earley, MD, FASAM

7:45 am – 8:30 amSession 17: Pregnancy and Women’s HealthErin Zerbo, MD

8:30 am – 9:15 amSession 18: Adolescents, Young Adults, and the Elderly Kenneth Thompson, MD, FASAM

9:15 am – 10:00 amSession 19: Pain and AddictionEdwin Salsitz, MD, FASAM

10:00 am – 10:30 amRefreshment Break

10:30 am – 11:15 amSession 20: Principles of Pharmacology and ToxicologyTimothy J. Wiegand, MD

11:15 am – 12:00 pmSession 21: Prevention and Public Health Mirela Feurdean, MD

12:00 pm – 12:45 pmSession 22: Ethics and the LawTimothy K. Brennan, MD, MPH

12:45 pm – 1:00 pmDay Three – Expert Panel Discussion and Q&A

Note: The order of presentations and faculty presenters may vary.

Schedule-at-a-Glance

3

ASAM Review Course in Addiction Medicine CurriculumIs mapped to ABAM’s 2015 Board Certification Examination Blueprint located on the ABAM website, www.abam.net

Section I: FOUNDATIONS OF ADDICTION MEDICINESession 1: Alcohol

• Alcohol• Pharmacological Interventions for Alcohol Dependence

Session 2: Sedatives• Benzodiazepines, Benzodiazepine Receptor Agonists, Barbiturates and

Other Sedative-Hypnotics• GHB• General Principles in Management of Intoxication and Withdrawal• Management of Alcohol Intoxication and Withdrawal• Management of Sedative-Hypnotic Intoxication and Withdrawal

Session 3: Opioids• Opioids (Opium, Heroin, Prescription Opioids)• Management of Opioid Intoxication and Withdrawal• Pharmacological Interventions for Opioid Dependence

Session 4: Tobacco• Nicotine and Tobacco• Management of Other Drug Intoxication and Withdrawal (Nicotine)• Pharmacological Interventions for Tobacco Dependence

Session 5: Cannabis• Cannabinoids• Management of Other Drug Intoxication and Withdrawal

(Cannabinoids)

Session 6: Stimulants • Cocaine, Amphetamine and Other Stimulants• MDMA• Management of Other Drug Intoxication and Withdrawal (Cocaine,

Stimulants)

Session 7: Other Classes of Drugs• Hallucinogens (LSD, Mescaline, Psilocybin, and Other Hallucinogens)• Dissociatives (Phencyclidine, Ketamine, Dextromethorphan and Other

Dissociatives)• Inhalants (Nitrous Oxide, Hydrocarbons and Other Inhalants)• Anabolic Steroids• Management of Other Drug Intoxication and Withdrawal

(Phencyclidine, Hallucinogens, Dissociatives, Inhalants, Steroids)• Pharmacologic Interventions for Other Drug Dependence• Pharmacological Interventions for Non-Substance Related Addictions

Session 8: Behavioral Addictions• Non-substance Addictions: Gambling, Sex, Food• Pharmacological Interventions for Non-Substance Related Addictions

Section II: ASSESSMENTS AND TREATMENTSSession 9: History of Addiction Treatment

• History of Addiction Medicine• Treatment of Alcohol Use Disorders• Treatment of Drug Use Disorders• Linking Addiction Treatment With Other Medical and Psychiatric Treatment• Alternative Therapies for Alcohol and Drug Addiction• Non-Substance Addictions: Gambling, Sex, Food• Treatment Needs of Children and Adolescents• Treatment Needs of Seniors• Quality Management in Addiction Treatment ◊ Outcome Measurement ◊ Satisfaction Measurement ◊ Performance Evaluation

Session 10: The Neurobiology of Addiction • Animal Models of Addiction• Neuropharmacology ◊ Acetylcholine ◊ Norepinephrine ◊ Dopamine ◊ Serotonin ◊ Gamma-Aminobutyric Acid (GABA) ◊ Glutamate and NMDA Receptors ◊ Other Amino Acids and Peptides ◊ Endogenous Opioids ◊ Endocannabinoids• Cellular and Molecular Mechanism in Addiction (Including Neuro-

Adaptation, Epigenetic Phenomena, etc.)• Neuro-Imaging of Addiction and Related Phenomena (Craving,

Relapse, Recovery, etc.)

Session 11: Epidemiology• Epidemiologic Associations and Interpretation• Biostatistics ◊ Vital Statistics and Demography ◊ Describing Data ◊ Hypothesis Testing ◊ Meta-Analysis ◊ Measurements of Morbidity and Mortality• Incidence, Prevalence, and Initiation

Session 12: Definitions, the ASAM Criteria & the DSM-5 • Definitions ◊ Addiction ◊ Addiction Medicine ◊ Unhealthy Use ◊ Dependence ◊ Withdrawal ◊ Detoxification ◊ Substance-Related Disorders ◊ ICD-10 Diagnostic Categories• ASAM Patient Placement Criteria and Appropriate Use of Levels of

Care

Session 13: Cognitive Behavior Therapy & Motivational Interviewing • Psychological Aspects of Alcohol and Drug Use, Intoxication and Addiction (Including “Set and Setting,” Placebo and Expectation) • Patient Engagement and Securing Treatment Entry • Motivating Patients to Change • Individual Psychotherapy • Cognitive Behavioral Therapy ◊ Relapse Prevention ◊ Community Reinforcement and Vouchers ◊ Contingency Management ◊ Matrix Model

Session 14: 12-Step Facilitation & Other Psychosocial Interventions

• Group Therapy• Self-Help Groups ◊ Twelve-Step programs and 12-Step Facilitation Therapies ◊ Other Self-Help Programs• Couples and Family Counseling, Therapies and Interventions• Residential Treatment and Therapeutic Communities• Treatment Retention and Chronic Disease Management• Comprehensive Case Management (Use of Integrated Medical Care

and Supplemental Services for Persons with Chronic, Persistent Addiction)

• Translating Research to Practice• Principles of Integrating Behavioral and Pharmacological Treatment

4

Session 15: Psychiatric Co-Morbidities • Neuropsychological Dysfunction (Problems With Attention, Memory, Learning, Executive Function) • Substance-Induced Mental Disorders • Affective Disorders • Posttraumatic Stress Disorder • Other Anxiety Disorders • Psychotic Disorders • Attention Deficit/Hyperactivity Disorder • Eating Disorders • Personality Disorders

Session 16: Medical Co-Morbidities • Management of Alcohol and Drug Withdrawal Among Those Hospitalized for an Acute Co-Morbid Condition (Including Critical Care Detoxification) • General Medical Evaluation and Management • General Medical and Surgical Complications ◊ Cardiovascular Consequences ◊ Hepatic Disorders ◊ Other Gastrointestinal Disorders ◊ Renal and Metabolic Disorders ◊ Respiratory Disorders ◊ Neurological Disorders ◊ Infectious Diseases (HIV, TB, Sexually Transmitted Infections and Others) ◊ Hematologic Disorders ◊ Sleep Disorders ◊ Acute Traumatic Injuries ◊ Rehabilitation From Traumatic Brain Injuries and Spinal Cord Injuries ◊ Terminal Illness, Palliative medicine and End-of-Life Issues ◊ Endocrine and Reproductive Disorders

Section III: SPECIAL POPULATIONS AND TOPICSSession 17: Pregnancy and Women’s Health • Heritability of Risk for Addition • Epigenetic Phenomena Related to Addiction • Genetic Predictors of Treatment Response • Special Populations: ◊ Women ◊ Pregnant Women and Newborns • Pharmacologic and Non-Pharmacologic Intervention for Neonatal Intoxication and Withdrawal for Opioids and Sedatives • Management of Adverse Impact and Long-Term Consequences of Alcohol on the Fetus • Obstetrical Complications and Pregnancy-Related Disorders and Complications • Drug Exposure, Including Fetal Alcohol Spectrum Disorders • Cognitive and Behavioral Diagnoses Secondary to In-Utero Alcohol and Drug Exposure

Session 18: Adolescents, Young Adults, & the Elderly • Special Populations: ◊ Injury/Trauma ◊ The Elderly ◊ Adolescents and Young Adults ◊ Families With Alcohol and Other Drug Using Members (Including Children at Risk) • Adolescent Relapse Prevention

Session 19: Pain and Addiction • Musculoskeletal and Orthopedic Problems • Chronic Non-Cancer Pain and Addiction • Psychological Issues in the Management of Pain • Non-Opioid Treatments in the Management of Pain • Opioid Treatments in the Management of Pain • Legal and Regulatory Considerations in Pain Management

Session 20: Principles of Pharmacology and Toxicology • Drug Metabolism and Principles of Drug Interactions (Including the Impact of Addictive Drug Use on the Metabolism of Common Therapeutic Medications) • Reinforcement • Tolerance • Cross-Tolerance • Physical Dependence • Conditioning • Sensitization • Impact of Route of Drug Administration (Oral, Sublingual, Intravenous, Inhalation, Intramuscular, etc.) • Alcohol and Drug Use in the Workplace:

◊ Clinical and Legal Considerations in Drug Testing ◊ Workplace Drug Testing ◊ Medical Review Officer (MRO) Responsibilities and Authority

Session 21: Prevention and Public Health • Primary Prevention • Secondary Prevention • Tertiary Prevention • Environmental Interventions to Reduce Alcohol, Tobacco and Other Drug Use • Prevention Programs ◊ High Risk Populations ◊ Educational Approaches ◊ Community Organizational Approaches ◊ Public Policy Approaches ◊ Regulation of Supply ◊ Demand Reduction

Session 22: Ethics and the Law • Ethical issues in Addiction Practice • Informed Consent and Confidentiality in Clinical Practice and Clinical Research • Clinical and Legal Considerations in Prescribing Drugs for Treatment of Addiction • Clinical and Legal Considerations in the Treatment of Minors ◊ Adolescent School-Based Drug Testing • Drug Courts and the Treatment of Incarcerated Populations • Licensing and Credentialing Issues for Health Professionals • Forensic Addiction Medicine: Expert Witness and Civil Commitment • Competency and the Assessment of Competence • Environmental Tobacco Smoke • Disability and Substance Use • Americans with Disabilities Act (ADA) • Medical Futility and End-Stage Addiction • Therapeutic Pessimism/Nihilism and Pseudo-Futility • Addiction Services Administration

5

NEW FEATURE!Board Exam Practice Questions Throughout The ASAM Review Course, Dr. Paul Earley will lead participants through six rounds of specially selected Board Exam Practice Questions using Audience Response technology. Test your knowledge and learn how to work your way through exam questions with the experts. See the complete schedule on page 3 for dates and times.

I am prepared for the exam. This is the best course that I have ever attended!

- 2014 Course Attendee, TX

Pre-Courses – Wednesday, July 29, 2015

Learn from the BEST - Registrants of the 2015 ASAM Review Course receive complimentary access to the 2015 Board Exam Study Tool – the BEST, an interactive learning tool that includes study material and competency questions to help prepare examinees in an engaging, self-paced format. This learning tool allows you to fully engage with the subject material. 2015 BEST users will be able to:

• Read excerpts from The Principles, 5th Edition • Review important definitions • Take notes and highlight key points • Bookmark challenging chapters • Study slides from the 2015 ASAM Review Course • Test your knowledge with self-assessment questions • Get tips on taking the ABAM Exam from the experts

Study on the go! The BEST can be accessed through supported mobile devices and tablets.

ASAM’s textbook, The ASAM Principles of Addiction Medicine, Fifth Edition, is the basic reference text for the Review Course. Speakers will refer to and draw from this text often as part of their presentations. Copies also will be available for purchase at the Review Course.

In addition, The ASAM Essentials of Addiction Medicine, Second Edition, is a quick reference book on virtually all addiction medicine topics. Both books are great study tools for the ABAM Certification Examination. As a supplement to the books, participants will receive a printed syllabus onsite at the course.

6

FOR OFFICE-BASED TREATMENT OF OPIOID USE DISORDERS

Tools and Resources

The ASAM Buprenorphine Waiver Eligibility Course12:30 pm – 4:45 pmAdditional Fees Apply

The Buprenorphine Course provides physicians with the 8 hours of training required to obtain the DEA waiver to prescribe buprenorphine in office-based treatment of opioid dependence under the Drug Abuse Treatment Act of 2000. The first half of the course is online through 4 hours of independent self-paced learning followed by a competency exam which must be successfully completed as part of the process to obtain a waiver for prescribing buprenorphine. The second half of the course is delivered by national experts in a 4 hour interactive, face to face classroom setting. For more information, visitwww.asam.org/reviewcoursebup

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society of Addiction Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credit (s)™.

Application has been made for The ASAM Buprenorphine Waiver Course to be an approved CME Activity by the American Board of Addiction Medicine (ABAM) for the Maintenance of Certification (MOC) Program for the CME requirement for Part II: Lifelong Learning and Self-Assessment.

The CO*RE/ASAM ER/ LA Opioid REMS Course5:45 pm – 9:00 pmFREE - Live or via Webinar

The CO*RE/ASAM ER/LA Opioid REMS course was developed by nationally renowned experts and incorporates all six units defined by the FDA blueprint for REMS education. ASAM also provides a unit addressing opioid use, pain, and addiction. This critical content will be presented through a variety of formats including lecture, case study, interactive audience response activities, and open discussion. For more information, visit www.asam.org/reviewcourserems

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society of Addiction Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credit (s)™.

This course has been designated as an approved CME Activity by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 3 AMA PRA Category 1 Credit(s)™ to the CME requirement for Part II: Lifelong Learning and Self-Assessment.

*NOTE: These courses are separate from The ASAM Review Course. Separate registration and fees apply.

Visit www.lww.com to purchase your copy of these valuable texts now or call 1-800-638-3030.

Abigail J. HerronTimothy Koehler Brennan

S E C O N D E D I T I O N

SE

CO

ND

ED

ITIO

NH

erron • BrennanA

ddiction Medicine

THE ASAM

ESSENTIA

LS OF

AddictionMedicine

THE ASAM ESSENTIALS OF

This is an excellent course for all physicians practicing or treating addiction.

- 2014 Course Attendee, LA

Payment Processed:Initials ____ Date ____ Data Entry Processed: Initials ____ Date ____

ASAM Member $640 $840

Associate Member $490 $690

Non-Member Physician $840 $1040

Non-Physician Professional* $640 $840

Federal Government $640 $840

Resident**

Medical Student** $150 $150

On or Before After Fee Description June 29th June 29th

The ASAM Review Course in Addiction MedicineWednesday, July 29 - August 1, 2015 | 5:45 pm - 9:00 pm

REGISTER ONLINE www.ASAMReviewCourse.org

July 29 - August 1, 2015Hilton Orlando Bonnet Creek

Orlando, FL

Use this form if you are unable to register online

PRE-CONFERENCE COURSES:

REGISTRANT INFORMATION: Name ________________________________________________________________

Degree(s)/Credentials ___________________________________________________Organization Name _____________________________________________________ Position/Title __________________________________________________________ Address _________________________________________________City ____________________________________ State ________ Zip Code ________ E-mail ___________________________________ Phone ______________________ Any Special Assistance Required ____________________________________________

Name on Badge ________________________________________________________

The CO*RE/ASAM ER/LA Opioid REMS: Achieving Safe Use While Improving Patient CareWednesday, July 29, 2015 - 5:45 pm - 9:00 pm

Wednesday, July 29, 2015 | 12:30 pm - 4:45 pm

Member: $50 Non-Member: $80

On-site Live Course Cost per person: FREE

By Check Only: Make check payable and mail to:2015 ASAM Review CourseP.O. Box 96118 Washington, DC 20090-6118

TO REGISTER:Total Enclosed

$ ________ Master Card Visa AMEX Discover

___________________________________________Authorized Signature:

____________________Exp. Date: ___________________ Security Code: _____________________________________________________________ CC#:

Credit Card Type:

By Credit Card: Online at www.ASAMReviewCourse.orgOr by Fax: 301-656-3815 or email to meetings@asam.org

Questions? Call 301-656-3920

Course registrants will be emailed a link with access to online portion of the course 8 weeks in advance. The online learning modules and quiz must be completed before attending the face-to-face classroom education on July 29. Certi�cates of attendance and CME Certi�cates will only be awarded to registrants who complete all 8 hours of the course.

NOTE: The ASAM Buprenorphine Course registration does not include the Full Review Course Registration. You must register in advance.

The ASAM Buprenorphine Course for Office-Based Treatment of Opioid Use Disorders

The ER/LA Opioid REMS course was developed by nationally known experts in the ER/LA opioid �eld. ASAM’s REMS course is CO*RE-branded material, but will also include a special focus on addiction medicine. Utilizing dynamic media presentation tools, this critical content will be presented through a variety of formats including lecture, case study, interactive audience response activities, and open discussion.

LIVE WEBINAR - For those unable to attend the course on-site, ASAM is o�ering a live-stream webinar option for the course. All attendees must register in advance in order to remotely experience the course on a computer or mobile device. Look for an email link with access to the webinar closer to the course date.

NOTE: The ER/LA Opioid REMS course registration does not include the Full Review Course Registration. You must register in advance or on site.

Live WebinarCost per person: FREE

(*) To find if you qualify for the Federal Government or Other Professional rates, call the Membership Department at (301) 656-3920

(**) Residents and Students must join as a Resident or Student Member of ASAM (Membership for Residents costs $36; there is no charge for Student Members, but verification of student status is required).

By attending this conference, attendees grant ASAM permission and consent to use photography and video from the conference for future Society promotions.

Special Needs: Individuals requiring auxiliary aids or services as identified in the Americans with Disabilities Act should contact ASAM at meetings@asam.org. Please put "Special Needs" in the subject line.

Cancellation policy: A $150 cancellation fee will apply to all cancellations received through Monday, June 29, 2015. There will be no refunds on cancellations received after Monday, June 29, 2015. All cancellation requests must be made in writing and sent to: ASAM Meetings Department, 4601 North Park Avenue, Upper Arcade, Suite #101, Chevy Chase MD, 20815. Questions: 301-656-3920 or meetings@asam.org.Refund procedure: Refunds will be processed after the conference. If payment is made by credit card, the adjustment will be made to your credit card account; otherwise a refund check will be issued. All refunds will be processed four to six weeks after the conference.

The course features a three-day program of outstanding speakers, supported by an extensive print and electronic syllabus. Registration fee includes the printed and electronic versions of the course syllabus, access to online Board Examination Study Tool (BEST), other reference materials, continental breakfast, and refreshment breaks.

$315 $575

HOTEL INFORMATION:Hilton Orlando Bonnet Creek14100 Bonnet Creek Resort Lane Orlando, FL 32821Discounted Hotel Rate: $139 single/double occupancy

A limited number of rooms are being held at the ASAM special course rate All reservations must be accompanied by an active registration to receive the discounted rate.

Conference Rate Deadline: Monday, June 29, 2015Reservation by Phone: 1-800-780-5727Reservation by Internet: http://bit.ly/1zL4gRX

The room reservation deadline does not ensure availability of rooms. Room reservations received after the deadline will be con�rmed subject to rate and room availability. Hotel room rates are subject to applicable state and local taxes

7

Use this form if you are unable to register online

4601 North Park Avenue, Upper Arcade, Suite #101Chevy Chase, Maryland 20815-4520

www.asamreviewcourse.org

Nonprofit Org.US Postage

PAIDPermit 178

Manassas, VA

REGISTERONLINE TODAY!

Continuing Medical Education Credits Accreditation Council for Continuing Medical Education (ACCME)The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Addiction Medicine designates this education activity for a maximum of 20.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABAM Maintenance of Certification Program (MOC)Application has been made for The ASAM Review Course to be an approved CME Activity by the American Board of Addiction Medicine (ABAM) for the Maintenance of Certification (MOC) Program for the CME requirement for Part II: Lifelong Learning and Self-Assessment.

American Academy of Family Physicians (AAFP)Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

Who Should Attend:• Physicians preparing for the 2015 ABAM Certification/Recertification Examination in Addiction Medicine.• Addiction specialists, seeking a "refresher" course that incorporates recent developments in addiction science and practice.• Non-specialist physicians and other health care Professionals, needing the knowledge to identify and manage problems related to substance use disorder.